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Surgery for hypertrophic cardiomyopathy is generally per- 
formed in patients who have a significant ieft ventricular 
outflow tract gradient and severe symptoms despite maximal 
medical therapy (l-4). The most commonty performed proce- 
dure is septal myectomy (the Morrow procedure) (S), which 
usually results in adequate reduction in the obstruction to 
outeow (6-9). Becauss of the contribution of the mitral valve 
in generating the outflow tract gradient (10-13). mitral valve 
replacement alone or in combination with myectomy is also 
performed, often with better hemodynamic results than those 
of myectomy alone (8,9,14,15). However, the long-term risks of 
thromboembolism and hemorrhage associated with prosthetic 
valves and the need for anticoagulant therapy make mitral 
valve replacement an unattractive option for many patients 
with hypertrophic cardiimyopathy. who are frequently young 
and physically active (1.16). Mitral leaget plication in combi- 
nation with myectomy has recently been proposed (17) as a 
successful alternative to mitral valve rep!xcment in hypertro- 
phic cardiomyopathy. Another alternative procedure is ante- 
rior mitral Ieatkt extension one of several valve repair tech- 
niques dcvelopcd by Cqenticr (18) and ChauMud et al. (19). 
in which a ghrtarakkhyde-preserved autologous pericardial 
patch is used to enlarge the mitral valve along its horizontal 
axis. The application of mitral lealiet extension in patients with 
ohstmaive hypettrophi cardiomyopathy has not been re- 
ported previously. In thii report we present the immediate 
results and e&y follow-up data (up to 4 years) in 8 patients 
treated with combined anterior mitral leaflet ester&n and 
myectomy. Results are compared with those of 12 patients 
lmdergoiug~fHnyalone.-rlIcpossiblenlccb*or 
action of mitral k&t extension are aIso di. 
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Methods 
Indications. Indications for surgery in our Hypertrophic 
Cardiomyopathy Clinic include a rest or provokable left ven- 
tricular outRow tract gradient 250 mm Hg and persistent 
symptoms despite an adequate trial of medical therapy, con- 
sisting of beta-adrenergic blocking agents, calcium channel 
blocking agents, or both. Preoperative echocardiography and 
cardiac catheterization for invasive hemodynamic measure- 
ments and angiography are performed in all patients for whom 
surgery is proposed. Postoperative assessment includes repeat 
echocardiography 1 week and again several months after 
operation. Repeat cardiac catheterization is not routinely 
performed unless clinically indicated. 
The decision to perform anterior mitral leaflet extension in 
conjunction with myectomy is made at the time of operation if, 
in the surgeon’s view, myectomy alone is likely to yield a 
suboptimal result. Conditions that favor inclusion of a valve 
procedure include atrial fibrillation, limited septal hypertro- 
phy, marked systolic anterior motion of the mitral valve and 
rigqificant mitral regurgitation (1,4,5). 
Patients. Between 1986 and 1988, the myectomy procedure 
was performed by two surgeons (L.A.H. and an older colleague 
who taught L.A.H. the myectomy procedure). From 1988 on, 
all operations, including all mitral valve procedures, were 
carried out by a single surgeon (L.A.H.). A total of 20 patients 
underwent septal myectomy, 8 of whom underwent concomi- 
tant anterior mitral leaflet extension. The primary reason for 
performing mitral leafle: extension was mitral regurgitation 
and systolic anterior motion of the mitral valve of particular 
severity; one patient had chronic atrial fibrillation associated 
with significant mitral regurgitation. 
Sorgicai technique. Open chest epicardial echocardiogra- 
phy is used extensively during the procedure for ongoing 
assessment of septal thickness, systolic anterior motion of the 
mitral valve and detailed structure of the mitral leaflets. 
Continuous wave and Doppler color echocardiography are 
used to quantify the outllow tract gradient and mitral regurgi- 
tation and their responses to physiologic mampulation such as 
volume mfusion and administration of inotropic agents. The 
images are registered on videotape for off-line analysis. Pa- 
tients are operated on with standard techniques of carciiopul- 
monary bypass with moderate hypothermia and crystalloid 
cardioplegic arrest (St. Thomas’s solution). An autologous 
pericardial patch is harvested, trimmed of fat and extraneous 
tissue, immersed for 10 min in 0.62% glutaraldehyde and then 
placed in a normal saline bath. The aorta is opened by an, 
oblique incision and septal myectomy is performed to the left 
of an imaginary line through the nadir of the right aortic cusp, 
with a locally designed electrocautery device, described in 
detail elsewhere (20). In brief, the cutting electrode of the 
device is a quadrangular monopolar electrode composed of a 
metal foil. The cutting electrode is connected to a pencil with 
a malleable connection to allow the electrode to be adjusted 
with respect to the orientation of the handle, The width and 
depth of the myectomy depend on the dimensions of the 
Figure 1. Schematic representation of mitral leaflet extension. The 
pericardial patch is clearly seen in the middle of the drawing, within 
the anterior mitral leaflet. The area of the myectomy is seen in the 
interventricular septum, demarcated by dots. The ostia of hnth the left 
(LCA) and right (RCA) coronary arteries are indicated for orientation 
pUlpOS.3. 
electrode. Currently, three different electrode sizes arc avail- 
able: 10 X 6.5. 11 X 9 and I6 X 9 mm (width X depth). The 
procedure is guided by intraoperative echocardiography with 
the removal of additional septal myocardium if necessary. 
Next, anterior mitr ‘1 leaflet extension is performed accord- 
ing to the method des:ribed by Chauvaud et al. (19X with the 
following modifications: the pericardial patch harvested at the 
beginning of the procedure is cut to an oval shape approxi- 
mately 3 cm wide and 2.5 cm long. The anterior mitral leaflet 
is incised longitudinally from its subaortic hinge point to the 
rough zone. The patch is sewn onto the ventricular surface of 
the leaflet at the site of the incision by using three running 
polypropylene monofilament sutures (Fig. 1). Immediate re- 
sults are assessed by intraoperative echocardiography after 
weaning from cardiopulmonary bypass, with particular atten- 
tion to residual systolic anterior motion, mitral regurgitation 
and the left ventricular outflow tract gradient. Reinstitution of 
bypass for the purpose of modifying the surgical result was not 
required in this cohort of patients. 
Data collection and analysis. All patients were assessed 
clinically preoperatively and postoperatively by the same phy- 
sician (F.J.T.C.), who was also responsible for their medical 
management. Transthoracic echocardiographic data were re- 
viewed by two physicians who had access to data on the 
patients’ histories and surgical procedures. Inter-ventricular 
septal thickness was determined by two-dimensional echocar- 
diography in the parastemal short-axis view at the site of the 
myectomy. Mitral regurgitation was assessed by color Doppler 
echocardiography and graded on a scale of 0 to 4+. Systolic 
anterior motion of the mitral valve ~8s assessed from the 
two-dimensional images and graded as 0 (absent), 1 t (mild 
[minimal mitral-sebtal distance >lO mm during systole]), 2t 
(moderate [mir,imal mitral-septal distance ~10 mm during 
systole]) or 3t (marked [brief or prolonged contact between 
the mitral valve and septum]) (21). Peak left ventricular 
outflow tract gradient at rest or with provocation was estimated 
with Doppler echocardiography by using the modified Ber- 
noulli equation, P = 4V*, where P is pressure gradient and V 
is Doppler-determined blood velocity. When echocardio- 
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Table 1. Preoperative and Postoperative Clinical and Transthoracic Echocardiographic Data of Patients With Hyp-ertrophic O&active 
Cardiomyopathy Treated With Either Combined Myectomy and Mitral Valve Extension or Myectomy AIone 
Peak LVOT 
IVS Width Graaient 
Pt Age W 
NYHA Cla\s 
Date of - 
Medication (mm MR SAM (mm Hg) -- ___ -_ ~ 
NO. Gender Operation Pre Post Prc P1*t Pre port Prc Pmt Pre PO%t Pre Post 
MMIMLE 
1 57/M ml III 1 A.C,D.W c-w 27 20 31 1; 3- 0 92 5 
2 25/F 9iuI III I B - 30 a 3+ IA 3+ l- 58 2.5 
3 2wv4 2192 111 I B.C - 35 2s 3+* 0 3- 0 74 9 
4 54/M 1,93 II I B - 22 15 3+ 0 2- 0 loll 9 
5 31,iM 3;93 111 I C 22 I5 l+ l- 3+ 0 112 36 
b 35:F 6% II I C C 29 20 ?+ 0 3+ 0 121 lb 
7 59,m bl‘% II) I B - 2. 31 18 2” (I 3t 0 loo b 
8 Jllff bP4 II I C C 20 15 3t l+ I- l- 100 34 
MM alone 
1 54M 3% III I C c.w 28 24 2+* l* 2; 2- 8D* lb 
? 29n- 8% 111 II C A 3u 2b 2-a j- 3r 3+ Ml xl 
3 52A 2187 111 II c.w B.D,W 27 18 l-* 1~ ?- (I 1lxJ I 
4 61/F 1 ?/X7 III I! B.C A,D.I.W 26 21 I- 0 l- II X0’ 5 
5 3x/M 7/m III II C B 30 25 I- 0 3+ I- 81’ 7 
b .UM ii/d8 II i c - 24 18 2+ I+ 3- 3- 16ll 41 
7 3OrF 5iX9 111 111 C B.C.D 25 19 1+ 0 l- 0 36 4 
8 38/M 7189 II I C c 20 20 0 0 I- l- kl 5 
9 ‘WM 3iu) !I1 II B B 33 3ll 0 0 2- l- SO t2 
10 36/F b/90 II I C A 30 22 0 0 3- 0 lfxl 36 
11 35,F J/91 III II B B 20 18 I+ 2-t 31 3+ 711 61 
12 WF 2i93 111 I B.C.W B,C,W 31 27 0 1+ 12 1+ 147 2.5 
*Assessed by angiography. A = antiarrhythmic agents; 6 = beta-adrenergic blocking agents; C = calcium channel blocker: D = diuretic drag; F = female: 1 = 
attgioteasin-mnwtingg enzyme inhibitor; IVS = interventricular system; LVOT = left ventricularoutllmv tract; M = male; MM = myectomy: MMMLE = myectomy 
and mitral valve extension; MR = mitral regurgitation; NYHA Class = New York Heart Asmiathn funaiond class: Post = p&operative: Pre = preoperative: Pt = 
patient: SAM = systolic anterior motion of the mitral valve; W = narfarin; - = none. 
graphic data were inadequate or unavailable, catheterization 
data were used. Intraoperative epicardial echocardiograms 
were performed in all patients before and after cardiopulmo- 
nary bypass. The recordings of those patients who underwent 
anterior mitral leaflet extension were available for further 
analysis. 
The left ventricular outflow tract and mitral valve leaflet 
areas were calculated according to previously described meth- 
ods (21,22). In brief, the left ventricular outflow tract area is 
calculated in the short-axis view at the level of the mitral valve 
at the onset of systole. The first frame in the cardiac cycle 
(onset of ventricular systole) when the mitral valve appears 
closed is taken for analysis. On the stop frame the innermost 
margins of the outflow tract are traced on the screen and the 
demarcated area is calculated by utilizing an off-line compu:er 
and a dedicated software program (23). The mitral valve leallet 
area is derived from the mitral valve opening area (MVOA). 
The latter is measured by tracing the innermost margins of the 
mitral valve in the parastemal short-axis view at the point of 
maximal opening. The’ mitral valve leaflet area (MLA) is then 
calculated by using the formula MU = 2.19 t 3.06 X MVOA 
validated by Klues et al. (22). 
Statistics. Data were expressed as mean value 5 SD. The 
Wilcoxon test was used to compare clinical characteristics 
before and after operation of the patients with combined 
myectomy and anterior mitral valve extension and those with 
myectomy alone. The characteristics compared were age, New 
York Heart Association functional class, number of drugs 
prescribed, width of the interventricular septum. severity of 
systolic anterior motion, severity of mitral insufficiency and left 
ventricular outflow tract gradient. 
Results 
Patient cbaracteristies and surgical outcome. Preoperative 
and postoperative clinical and transthoracic echocardiographic 
characteristics of the 8 patients undergoing myectomy com- 
bined with anrcrior mitral valve extension and the 12 patients 
undergoing myectomy alone are presented in Table 1. The 
postoperative clinical and echocardiographic data refer to the 
latest patient follow-up. There were no deaths or serious 
complications astiated with the surgical procedures. Patients 
4 and 6 in the group with myectomy alone died during 
follow-up: Patient 4 died of congestive heart failure 6 years 
after operation and Patient 6 died suddenly 2 years afier the 
procedure. 
Statistical differences between the two groups are preseoteu 
in Table 2. Preoperative mitral regurgitation and systolic 
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Table 2. Baseline and Postoperative Characteristics in Patients combined myectomy and mitral valve extension were calcu- 
Treated by Myectomy and Ivlitral Valve Extension and in Patients 
Treated by lvlyectomy Alone 
lated from intraoperative epicardial echocardiographic data 
according to previously described methods. The mean mitral 
P valve leaflet area of 15.9 + 2.0 cm2 is considerably above mean 
MM/M-E MM Value 
Baselime 
Age 0 42~10 41 2 10 0.94 
NYHAclars 2.6 2 0.5 2.8 2 OS o.s9 
Number of drugs 1,s + 1.1 1.3 c 0.7 0.96 
IVS width (mm) 26 + S 21 i4 0.56 
Range 20-3s 20-33 
MR’ (grade) 2tl3t oj2+ c 0.001 
SAMt (grade) 2+/3t 1t/3+ c 0.05 
LVOT gradient (mm Hg) 9s f 20 81~ 36 0.33 
Postoperative 
NYHA class 1 1.7 2 0.7 0.0s 
Number of drugs 0.5 2 0.8 1.8 2 1.2 c o.oQs 
IVS width (mm) 19 f 4 22 '-4 c 0.05 
Range 15-z IS-30 
MR* (grade) o/1+ o/3+ c 0.00s 
S‘QU (PW O/l t 0/3t < 0.01 
LVOT gradient (mm H.e,) 18 5 13 23 2 20 0.35 
‘Range of mitral regurgitation observed in the two respective patient groups. 
tRange of systolic anterior motion observed in the two respective patient groups. 
Data are presented as mean value i: SD, range or grade. IVS = width of the 
interventricular septum; other abbreviations as in Table 1. 
anterior motion of the mitral valve were worse (p < 0.001 and 
p < 0.05, respectively) in the patients who underwent com- 
bined myectomy and mitral valve extension than in the patients 
who underwent myectomy alone. Nonetheless, postoperative 
residual mitral regurgitation and systolic anterior motion were 
significantly better (p < 0.005 and p < 0.01, respectively) in the 
group with the combined procedures. Moreover, this group 
had greater improvement in functional class @ = 0.05) and a 
greater reduction in both the number of drugs prescribed @ < 
0.005) and the width of the interventricular septum (p < 0.05). 
MItd v&e ummtrenteats. The mitral valve ieaflet and 
left ventricular outflow tract areas of patients undergoing 
values for the general population (cl2 cm*).- All patients 
belonged to a subset of patients with hypertrophic cardiomy- 
opathy, as described by Klues et al. (24), with enlarged mitral 
leaflets, relatively large left ventricular outtlow tract area (22.0 
cm* [mean 2.9 + 0.71) and a distinctive sharp-angled bend of 
the anterior mitral leaflet. 
By transthoracic echocardiography, the anterior mitral 
valve extension procedure did not induce obvious changes in 
the length or thickness of the anterior mitral leaflets, although 
subjectively they appeared somewhat less flexible. Figure 2 
shows a typical postoperative transthoracic echocardiogram 
without any residual systolic anterior motion of the mitral valve 
and with a widened left ventricular outflow tract. 
Discussion 
Anterior mitral leaflet extension is a novel surgical ap- 
proach to the treatment of obstructive hypertrophic cardiomy- 
opathy. The procedure entails grafting a patch of autologous 
pericardium onto the center portion of the anterior mitral 
leaflet, effectively increasing the size (mainly the width) of the 
leaflet. In the eight patients who underwent anterior mitral 
IeatIet extension in combination with septal myectomy, the 
extension procedure was safe and effective in abolishing or 
greatly reducing systolic anterior movement of the mitral valve 
and mitral regurgitation and in lessening symptoms. Patients 
undergoing the combined procedure had signi@antly greater 
improvement in functional class and required fewer number of 
drugs postoperatively than did the 12 patients undergomg 
myectomy alone. 
The reduction of septal thickness in both groups is not in 
contrast to the results of other institutions (25-27). Neverthe- 
less, our approach may not be as aggressive as the double 
Figure 2. Twodimensional, long-axis transthoracic 
echocardiograms from the same patient before and 
after combined anterior mitral leaflet extension 
and myectomy. Roth are systolic frames from the 
same Point in the cardiac cycle. Left, Preoperative 
image (PRE), demonstrating marked systolic ante- 
rior motion of the distal anterior mitral leaflet 
@Al& sin& arrow). Rig& Postoperative image 
(POST), showing no significant systolic anterior 
movement of the valve. Note also the widened 
out&w tract after myectomy and the probable 
Position of the pericardial patch (double arrows). 
The mitral valve itself is not demonstrably longer 
or thicker, although differences in technical quality 
prevent direct comparison. IVS = interventricular 
se@um; LV = left ventricle; LVOT = leti ventric- 
i ular out&w tract. / I 
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myotomy-myectomy procedure reported by Morrow (28). 
However, oveaealous septal myectomy must be avoided, be- 
cause it may cause complete heart block, septal defect or 
increased mortality (29-31). The optimal myectomy procedure 
reduces septal thickness to a minimum without augmenting 
morbidity and mortalit$ Starting in 1972 we performed myec- 
tomy with or without mitral valve extension in 46 patients with 
only 1 in-hospital death. We cannot exclude the possibility ihat 
these good results were obtained because of a less aggressive 
septal myectomy. 
Although the principal benefit of anterior mitral leaflet 
extension appears to be abolition of systolic anterior move- 
ment and mitral regurgitation, the precise mechanism of this 
effect is not clear. In fact, the idea of enlarging the anterior 
mitral leaflet is counterintuitive, given the awareness of the 
role that the mitral valve plays in producing the systolic 
anterior movement. 
Mechanisms of oufflow tract obstruction. Outflow tract 
obstruction in patients with hypertrophic cardiomyopathy re- 
sults from a combination of left ventricular outflow tract 
narrowing, due to basal septal hypertrophy, and systolic ante- 
rior motion of the mitral valve (1,I 1,32). Several mechanisms 
for systolic anterior motion have been proposed: I) The 
Venturi mechanism, by which the hypertrophied septum and 
anterior displacement of the mitral valve create outflow tract 
narrowing, increased flow velocity, decreased pressure above 
the valve and, consequently, the development of systolic ante- 
rior motion, partly due to the abnormal laxity of the mitral 
valve (10,12-14.22,24,32-35). 2) Anatomic alterations in the 
mitral valve apparatus. These may predispose to systolic ante- 
rior motion due to flow drag, the combination of increased 
mitral leaflet area, length and laxity and anterior displacement 
of the papillary muscles allowing the mitral leaflets to protrude 
into the left ventricular outflow tract and thus exposing them tt) 
flow drag. 3) Inward displacement of the papillary muscles 
toward one another. This displacement can produce relative 
chordal slack in the central leaflet portions; consequently, the 
systolic anterior motion will be greatest in the center of the 
valve (36). 
Recently a timbined pathologic and echocardiographic 
re-Iiew by I&es et al. (24) confirmed that an enlarged mitral 
valve is present in a subset of patients with hypertrophic 
cardiomyopathy. These investigators classified patients with 
obstructive hypertrophic cardiomyopathy into the categories: 
1) patients with an enlar;;cd mitral valve, relatively large left 
ventricular outflow tract area and distinctive sharp-angled 
bend of the anterior leaflet (typical systolic anterior motion). 
and 2) patients with a normal-sized mitral valve. small outflow 
tract area and “atypical” systolic anterior motion. All of our 
patients treated by the combined myectomy-mitral vahe ex- 
tension technique belonged to the subset of patients with an 
enlarged mitral valve. This finding is important because an 
enlarged mitral valve may predispose to residual systolic 
anterior motion of the valve after myectomy, resulting in a 
suboptimal outcome with persisting outflow tract obstruction. 
Possible mechanisms of action of mitral leaflet extension. 
How, then, does further increasing the size of the anterior 
mitral leaflet with a pericardial patch abolish the systolic 
anterior motion? Both the Venturi mechanism and the flow 
drag of the leaflets described earlier may be counteracted by 
anterior mitral’leaflet extension. ‘The distal end of the patch 
lies in the proximity of the bending point of the anterior leaflet. 
The patch may merely serve tc stiffeo :he leaflet, making it less 
lax and less likely to buckle in the presence of Venturi forces 
or flow drag forces. Subjectively, the anterior mitral leaflets 
after combined myectomy and mitral valve extension did 
appear less “floppy” by two-dimensional echocardiography, 
without compromise in leatlet mobility or coaptation. 
The mitral valve extension technique increases the width 
(horizontal dimension), not the length (vertical dimension), of 
the anterior leaflet. Conceivably, increasing the width of the 
anterior mitral leaflet could erect the relatively lax chordae 
attaching central portions of the mitral leaflet and thus prevent 
buckling of central parts of the valve. 
Currently we perform the mitral valve elongation procedure 
in patients undergoing surgery who are likely to have subopti- 
mal results from myectomy alone. These may include patients 
with particularly severe systolic anterior motion of the mitral 
valve and mitral regurgitation, as well as patients with chronic 
atrial fibrillation or limited septal hypertrophy. In retrospect, 
all of our patients who underwent combined myectomy and 
anterior mitral valve elongation belonged to the subset of 
patients with an abnormally enlarged anlerior mitral leaflet 
surface area. Whether equal results can be achieved in patients 
with a normal-sized mitral valve is unknown. 
Summary. Adequate and predictable relief of outflow tract 
obstruction is the primary goal of surgery for hypertrophic 
cardiomyopathy. Many techniques. including simple septal 
myectomy, extended myectomy using intraoperative echocar- 
diography and multiple periods of cardiopulmonary bypass 
(31), mitral valve replacement (l&9) and mitral leaflet plica- 
tion (17). are currently available to the cardiac surgeon. 
Anterior mitral valve extension is a promising new surgical 
approach to obstructive hypertrophic cardiomyopathy that may 
provide more satisfactory results than those of myectomy 
alone. The mitral valve extension procedure is known to be a 
safe and reliable therapy in other conditions such as rheumatic 
valve disease and bacterial endocarditis with perforation (19). 
Further experience needs to be gained in obstructive hyper- 
trophlc cardiomyopathy before its widespread use can be 
recommended. 
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